CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 91 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $154,000 | -81.6% | 17,500 | -68.9% | 0.08% | +70.8% |
| Q3 2018 | $835,000 | -48.9% | 56,297 | -42.1% | 0.05% | -50.0% |
| Q2 2018 | $1,635,000 | -50.6% | 97,200 | -32.8% | 0.10% | -54.7% |
| Q1 2018 | $3,311,000 | +83.1% | 144,600 | -19.2% | 0.21% | +44.2% |
| Q3 2016 | $1,808,000 | -41.1% | 178,900 | -34.6% | 0.15% | -48.8% |
| Q2 2016 | $3,070,000 | -25.9% | 273,400 | -9.9% | 0.29% | -31.5% |
| Q1 2016 | $4,145,000 | -29.8% | 303,500 | -2.5% | 0.42% | -44.3% |
| Q4 2015 | $5,903,000 | +2.8% | 311,200 | +1.6% | 0.75% | +0.8% |
| Q3 2015 | $5,743,000 | +125.0% | 306,300 | +78.7% | 0.75% | +109.0% |
| Q2 2015 | $2,552,000 | +64.9% | 171,400 | +67.5% | 0.36% | +65.3% |
| Q1 2015 | $1,548,000 | +5.4% | 102,300 | -7.4% | 0.22% | -12.6% |
| Q4 2014 | $1,468,000 | +75.0% | 110,500 | +65.4% | 0.25% | +96.0% |
| Q3 2014 | $839,000 | +459.3% | 66,800 | +348.3% | 0.13% | +472.7% |
| Q2 2014 | $150,000 | -40.2% | 14,900 | -20.3% | 0.02% | -43.6% |
| Q1 2014 | $251,000 | – | 18,700 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,200,000 | $37,532,000 | 7.45% |
| BVF INC/IL | 2,336,609 | $39,863,000 | 6.78% |
| ISZO CAPITAL MANAGEMENT LP | 152,988 | $2,610,000 | 4.54% |
| SENZAR ASSET MANAGEMENT, LLC | 416,845 | $7,111,000 | 1.80% |
| INGALLS & SNYDER LLC | 1,056,000 | $18,015,000 | 0.96% |
| Lyon Street Capital, LLC | 86,011 | $1,467,000 | 0.59% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 430,982 | $7,353,000 | 0.25% |
| AWM Investment Company, Inc. | 137,212 | $2,340,000 | 0.22% |
| ACUTA CAPITAL PARTNERS, LLC | 49,051 | $837,000 | 0.20% |
| Schonfeld Strategic Advisors LLC | 61,831 | $1,055,000 | 0.11% |